Amikacin and Cephalothin: Empiric Regimen for Granulocytopenic Cancer Patients

Amikacin (15 mg/kg per day) was used in combination with cephalothin (7 g/m(2) per day) as an empiric regimen for de novo febrile (>101°F [38.3°C]) episodes in 93 granulocytopenic (<1,000/mm(3)) cancer patients. Both drugs were given intravenously in four equal doses every 6 h. The response ra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hahn, Davis M., Schimpff, Stephen C, Young, Viola Mae, Fortner, Clarence L., Standiford, Harold C., Wiernik, Peter H.
Format: Artigo
Idioma:Inglês
Publicat: 1977
Matèries:
Pharmacology and Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC429987/
https://ncbi.nlm.nih.gov/pubmed/335967
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars